Astrana Health Files 8-K on Financials
Ticker: ASTH · Form: 8-K · Filed: May 7, 2024 · CIK: 1083446
| Field | Detail |
|---|---|
| Company | Astrana Health, INC. (ASTH) |
| Form Type | 8-K |
| Filed Date | May 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, reporting
TL;DR
Astrana Health dropped an 8-K, check the financials.
AI Summary
Astrana Health, Inc. filed an 8-K on May 7, 2024, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibits. The company, formerly known as Apollo Medical Holdings, Inc., is incorporated in Delaware and headquartered in Alhambra, California.
Why It Matters
This filing provides investors with updated financial information and operational details for Astrana Health, Inc., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Astrana Health, Inc. (company) — Registrant
- Apollo Medical Holdings, Inc. (company) — Former company name
- May 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Alhambra, California (location) — Principal Executive Offices
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The filing indicates that 'Financial Statements and Exhibits' are being reported, but the specific details of these documents are not provided in the excerpt.
When was the company's name last changed?
The company's name was last changed from Apollo Medical Holdings, Inc. on July 15, 2008.
What is Astrana Health's Standard Industrial Classification code?
Astrana Health's SIC code is 8742, which corresponds to SERVICES-MANAGEMENT CONSULTING SERVICES.
What is the business phone number for Astrana Health?
The business phone number listed for Astrana Health is (626) 282-0288.
What is the fiscal year end for Astrana Health?
The fiscal year end for Astrana Health is December 31st.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-05-07 16:16:25
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share ASTH The Nasdaq S
Filing Documents
- tm2413600d1_8k.htm (8-K) — 26KB
- tm2413600d1_ex99-1.htm (EX-99.1) — 151KB
- tm2413600d1_ex99-2.htm (EX-99.2) — 35KB
- image_001.jpg (GRAPHIC) — 7KB
- tm2413600d1_ex99-2img001.jpg (GRAPHIC) — 257KB
- tm2413600d1_ex99-2img002.jpg (GRAPHIC) — 334KB
- tm2413600d1_ex99-2img003.jpg (GRAPHIC) — 207KB
- tm2413600d1_ex99-2img004.jpg (GRAPHIC) — 167KB
- tm2413600d1_ex99-2img005.jpg (GRAPHIC) — 113KB
- tm2413600d1_ex99-2img006.jpg (GRAPHIC) — 118KB
- tm2413600d1_ex99-2img007.jpg (GRAPHIC) — 113KB
- tm2413600d1_ex99-2img008.jpg (GRAPHIC) — 128KB
- tm2413600d1_ex99-2img009.jpg (GRAPHIC) — 124KB
- tm2413600d1_ex99-2img010.jpg (GRAPHIC) — 188KB
- tm2413600d1_ex99-2img011.jpg (GRAPHIC) — 125KB
- tm2413600d1_ex99-2img012.jpg (GRAPHIC) — 126KB
- tm2413600d1_ex99-2img013.jpg (GRAPHIC) — 90KB
- tm2413600d1_ex99-2img014.jpg (GRAPHIC) — 132KB
- tm2413600d1_ex99-2img015.jpg (GRAPHIC) — 220KB
- tm2413600d1_ex99-2img016.jpg (GRAPHIC) — 120KB
- tm2413600d1_ex99-2img017.jpg (GRAPHIC) — 209KB
- tm2413600d1_ex99-2img018.jpg (GRAPHIC) — 168KB
- tm2413600d1_ex99-2img019.jpg (GRAPHIC) — 189KB
- tm2413600d1_ex99-2img020.jpg (GRAPHIC) — 141KB
- 0001104659-24-058018.txt ( ) — 4919KB
- ameh-20240507.xsd (EX-101.SCH) — 3KB
- ameh-20240507_lab.xml (EX-101.LAB) — 33KB
- ameh-20240507_pre.xml (EX-101.PRE) — 22KB
- tm2413600d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On May 7, 2024, Astrana Health, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2024. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2 , respectively, and incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 2.02, including Exhibit 99.1 and Exhibit 99.2 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Astrana Health, Inc. Regarding its Financial Results for the Three Months Ended March 31, 2024, dated May 7, 2024. 99.2 Supplemental Data of Astrana Health, Inc., dated May 7, 2024. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: May 7, 2024 By: /s/ Brandon Sim Name: Brandon Sim Title: Chief Executive Officer and President